Immune monitoring of immunosuppression withdrawal of liver transplant recipients (Q42480438)

1 November 2017

Immune monitoring of immunosuppression withdrawal of liver transplant recipients (English)

1 reference

1 November 2017

1 reference

2

1 reference

1 November 2017

4

1 reference

1 November 2017

Rocío García de la Garza

Rocío García de la Garza

1

0 references

Mercedes Iñarrairaegui

Mercedes Iñarrairaegui

9

0 references

Iosu Sola

Iosu Sola

11

0 references

Bruno Sangro

Bruno Sangro

10

0 references

Delia D'Avola

5

Delia D'Avola

1 reference

1 November 2017

8

Leyre Silva

1 reference

1 November 2017

6

Virginia Belsue

1 reference

1 November 2017

Juana Merino

3

1 reference

1 November 2017

José A Delgado

7

1 reference

1 November 2017

Fernando Pardo

12

1 reference

1 November 2017

Jorge Quiroga

13

1 reference

1 November 2017

J Ignacio Herrero

14

1 reference

1 November 2017

27 July 2015

1 reference

1 November 2017

Transplant Immunology

1 reference

1 November 2017

33

1 reference

1 November 2017

110-116

1 reference

1 November 2017

2

1 reference

What is the real gain after liver transplantation?

1 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

Immunosuppression withdrawal improves long-term metabolic parameters, cardiovascular risk factors and renal function in liver transplant patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

Hot-topic debate on tolerance: immunosuppression withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

Long-term outcome after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

De novo malignancies following liver transplantation: impact and recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

Weaning of immunosuppression in liver transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

Defining the outcome of immunosuppression withdrawal after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

Weaning of immunosuppression in living donor liver transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

Operational tolerance in clinical liver transplantation: emerging developments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

Operational tolerance after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

Multiparameter immune profiling of operational tolerance in liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

Tolerance: is it worth the risk?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

Trial of complete weaning from immunosuppression for liver transplant recipients: factors predictive of tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

NK cells promote transplant tolerance by killing donor antigen-presenting cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

NK cells promote islet allograft tolerance via a perforin-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

Identification of a B cell signature associated with renal transplant tolerance in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

Comparison of transcriptional and blood cell-phenotypic markers between operationally tolerant liver and kidney recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

Late and chronic antibody-mediated rejection: main barrier to long term graft survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

Relationship between TH1/TH2 cytokines and immune tolerance in liver transplantation in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

Anti-IL2 induction in liver transplantation with 93% rejection-free patient and graft survival at 18 months.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2015.07.006

10.1016/J.TRIM.2015.07.006

7 January 2021

Identifiers

DOI

1 reference

1 November 2017

1 reference